Table 4.
Analyte | Post-treatment (G3) | P, H1 versus G3 | P, H2 versus G3 | P, G1 versus G3 | P, G2 versus G3 |
---|---|---|---|---|---|
| |||||
IL-1β (pg/mL) | 17.4 ± 21.9 | 0.302 | 0.734 | 0.247 | 0.055 |
IL-6 (pg/mL) | 4.5 ± 9.1 | 0.765 | 0.714 | 0.652 | 0.368 |
MMP-8 (ng/mL) | 179.9 ± 163.9 | 0.966 | 0.719 | 0.570 | 0.134 |
MIP-1α (pg/mL) | 8.6 ± 10.4 | 0.014 | 0.006 | 0.402 | 0.500 |
PGE2 (ng/mL) | 735.5 ± 754.6 | 0.037 | 0.001 | 0.526 | 0.364 |
Values in bold have P values <0.05 by Wilcoxon signed-rank (within groups) and rank-sum (between groups) tests.